Rubratoxin B and chick embryogenesis: An experimental study

Rubratoxin B and chick embryogenesis: An experimental study

ENVIRONMENTAL RESEARCH 20, 199-204 Rubratoxin (1979) B and Chick Experimental Embryogenesis: Study SHAMSHAD H. GILANI,JAMESBANCROFT, Department...

1MB Sizes 0 Downloads 28 Views

ENVIRONMENTAL

RESEARCH

20, 199-204

Rubratoxin

(1979)

B and Chick Experimental

Embryogenesis: Study

SHAMSHAD H. GILANI,JAMESBANCROFT, Department

of

Anatomy.

AND MURIELREILLY

Nets Jersey Medical New Jerse.v 07103

Received

September

An

School.

Newark.

2 I. 1978

The effects of rubratoxin B :verr studied on the chick embryos of l-3 days of incubation (groups A. B, and C). Rubratoxin B was dissolved in propylene glycol and injected into the air sacs of the eggs at doses ranging from 0.0005 to 0.007 mg per egg. The controls received an equal amount of propylene glycol only (0. I ml per egg). All the embryos including controls were examined at Day 7. In all, 720 eggs were utilized for this investigation. The percentage survival of the embryos on incubation Day 7 ranged from 67 to 40 in group A. 77 to 43 in group B. and 93 to 60 in group C. The LDSUfor the embryos treated on Days I and 2 was 0.001 and 0.005 mg per embryo. respectively. Gross malformations such as short and twisted limbs, short and twisted neck, exencephaly, microphthalmia, everted viscera, reduced body size, and hemorrhage over the body were observed. The frequency and the types of gross abnormalities did not vary much in all the groups. The incidence of malformations in the controls was low. Microscopic examination of Day 1 treated embryos (group A) showed the various types of cardiac anomalies. These include aortic stenosis, ventricular septal defect, thin ventricular wall, atria1 septal defects, and malformations of the valves. The incidence of these cardiac anomalies was low in the experimental embryos. No cardiac anomalies were observed in the control embryos. The results of the present study indicate that rubratoxin B is teratogenic to the overall development of the chick embryos including heart.

INTRODUCTION

Rubratoxin B, a metabolite of Pencillium rubrum, is a mycotoxin that produces hepatitis, nephrosis, and tissue hemorrhage in swine and cattle (Sippel et al.. 1953). In a very comprehensive study, Wogan et al. (1971) noted that chronic treatment of rubratoxin B leads to lesions of liver and spleen, hemorrhagic and congestive lesions of lymph nodes, subendocardial hemorrhage, adrenocortical congestion, and marked edema of the serosal surface of gallbladder in cats and other laboratory animals. There are reports demonstrating that rubratoxin B can induce teratogenic responses in the experimental animals. Koshakji et al. (1973) observed that rubratoxin B was both embryotoxic and teratogenic when administered intraperitoneally to pregnant mice. Hood et al. (1973) found that single intraperitoneal injection of rubratoxin B resulted in significant increases in embryonic mortality. The most common defects noted were exencephaly, malformed pinnae, malformed jaws, umbilical hernias, and open eyes. Evans and Harbison (1977) found rubratoxin B both mutagenic and teratogenic in mice and concluded that the structural requirement for this activity is an c-w-p-unsaturated lactone ring. The present series of experiments was designed to further investigate the teratogenic potential of this mycotoxin on the chick embryogenesis with special emphasis on the heart development. 199 0013-9351/79/050199-06$02.00/O Copyright All rights

@ 1979 by Academic Press. Inc of reproduction in any form reserved.

200

GILANI,

BANCROFT,

MATERIALS

AND REILLY

AND METHODS

Chick embryos of White Leghorn strain were used for all the experiments. The fertile eggs were incubated in a forced draft chick incubator operated at 385°C and a relative humidity of 60-65%. Rubratoxin B was dissolved in propylene glycol and was sterilized prior to injection by passage through a Millipore filter. The injections were made into the air sacs of the eggs at doses ranging from 0.0005 to 0.007 mg per egg on the lst, 2nd, and 3rd days of incubation, respectively (groups A, B, and C). The volume of fluid injected was 0.1 ml per egg. The controls received an equal amount of propylene glycol. Seven batches of eggs (30 eggs per batch) were used each in groups A, B, and C, respectively. In addition, one batch (30 eggs) of controls was utilized for each group. In all, 720 eggs were used. All the embryos were studied on the 7th day of incubation. After noting gross malformations, the embryos were fixed in Bouin’s fluid or in 10% neutral formalin. They were then dehydrated and stored in cedar wood oil. The percentage survival of the embryos indicated that group A (Day 1) was more sensitive to rubratoxin B than the embryos of groups B and C (Days 2 and 3; Table 1). It was therefore considered of interest to examine the embryos of group A for the possible cardiac anomalies. Five embryos from each batch with doses ranging from 0.0007 to 0.005 mg per egg were selected for microscopic sectioning. Histogenetic studies were made with cross and longitudinal sections at 6-8 pm. Tissue sections were stained with hematoxylin and eosin. RESULTS

The percentage survival of the embryos on incubation Day 7 ranged from 67 to 40 in group A, 77 to 43 in group B, and 93 to 60 in group C with similar doses (0.0005-0.007 mg per egg; Table 1). The percentage of embryos that survived decreased as the doses of rubratoxin B were increased in all the groups. Within all the groups, groups A and B appeared to be more sensitive to rubratoxin B than group C. The LD,,for the embryos of groups A and B was 0.001 and 0.0005 mg per egg, respectively (Table 1). TABLE THE PERCENTAGE SURVIVAL THE ADMINISTRATION

1

OF CHICK EMBRYOS ON INCUBATION DAY 7 AFTER OF RUBRATOXIN B ON DAYS 1, 2, AND 3”

Dosage WWegg)

Day 1 (Group A) (%o)

Day 2 (Group B) (%)

Day 3 (Group C) (%,)

0.0005 0.0007 0.0009 0.001 0.003 0.005 0.007

67 63 63 50 40 43 40 87

77 77 73 63 63 50 43 90

93 90 87 77 77 77 60 93

Controls (Propylene glycol)

u Seven batches of eggs (30 eggs per batch) were used each in groups A, B, and C. In addition, one batch (30 eggs) of controls was utilized for each group. In all, 720 eggs were used.

RUBRATOXIN

FREQUENCY OF CONGENITAL TREATED ON DAY 1 (GROUP

I’ Abnormalities abnormality.

were

TABLE 2 ABNORMALITIES IN SURVIVING CHICK A) WITH RUBRATOXIN B AND EXAMINED of abnormalities

EMBRYOS ON DAY 7

t%)” -

Reduced body size

20 19 19 15 12 13 12 26

0.0005 0.0007 0.0009 0.001 0.003 0.005 0.007 Control (Propylene dYCOl)

201

EMBRYOGENESIS

Types

No. of surviving embryos

Dosage hg/egg)

B AND

10 16 21 20 25 23 25 4

noted

Abnormal limbs

Abnormal neck

15 16 21 33 33 31 25 8

in the live embryos.

Exencephaly

15 21 21 33 33 31 25 8

A large

Microphthalmia 0 0 16 20 42 46 33 0

0 0 16 20 42 46 33 0

number

Everted viscera

of embryos

showed

1R 16 0 20 25 ‘3 25 4

more

than one

The teratogenic effects of rubratoxin B were observed all over the body of the embryos in all the groups (Tables 2-4). The gross abnormalities induced by rubratoxin B included microphthalmia (Fig. l), exencephaly (Fig. 2), short and twisted limbs, everted viscera, reduced body size, and hemorrhage all over the body. Within all the groups (A, B, and C), the frequency and types of gross malformations did not vary much. Thetypes of cardiac anomalies observed in embryos in group A included aortic stenosis, ventricular septal defects, thin ventricular walls, atria1 septal defects, and malformations of the valves. The incidence of these cardiac anomalies was

FREQUENCY

Dosage Wkg) 0.0005 0.0@07 0.0009 0.001 0.003 0.005 0.007 Control (Propylene glycol) ’ Abnormalities anomaly.

TABLE 3 OF CONGENITAL ABNORMALITIES IN SURVIVING CHICK (GROUP B) WITH RUBRATOXIN B AND EXAMINED Types

No. of surviving embryos

Reduced body size

24 24 22 19 19 15 13 27

were

13 13 14 21 21 26 23 3

noted

Abnormal limbs 13 17 14 26 21 20 30 3

in the live embryos.

Abnormal neck

of abnormalities

Exencephaly

13 17 14 26 21 20 30 3

A large number

EMBRYOS TREATED ON DAY 7

ON DAY 2

(%)”

Everted viscera

Microphthalmia

0 13 23 21 16 20 23 0

of embryos

0 13 23 21 16 20 23 0

showed

0 0 0 16 16 33 37 0

more

than one

202

GILANI,

BANCROFT, TABLE

FREQUENCY

OF CONGENITAL (GROUP

ABNORMALITIES C) WITH RUBRATOXIN

AND REILLY 4

IN SURVIVING CHICK B AND EXAMINED

EMBRYOS ON DAY

TREATED 7

ON DAY

3

Types of abnormalities (%)”

No. of surviving embryos

body size

limbs

neck

0.0005 0.0007 o.ooo9 0.001 0.003 0.005 0.007 Control (Propylene &!lYCOl)

28 27 26 24 24 24 18 28

7 7 8 13 13 13 17 7

11 15 15 21 21 17 27 7

14 15 15 21 21 17 27

0

0

13 17

0

0

13 17 7

a Abnormalities abnormality.

were noted in the live embryos. A large number of embryos showed more than one

Dosage hih3)

Reduced

Abnormal

Abnormal

Exencephaly 0 0 0 0

Microphthalmia

Everted viscera 0

7 8 13

FIG. 1. Seven-day chick embryos. Embryo at left is from a control group and is normal. Embryo at right is treated with rubratoxin B (0.001 mg per egg) on Day 1 and shows reduced body size and severe microphthalmia. x4.

RUBRATOXIN

B AND

EMBRYOGENESIS

203

low in the rubratoxin B treated embryos. Of 20 surviving embryos, 4 showed cardiac anomalies. No cardiac anomalies were observed in the control embryos. DISCUSSION

The experiments reported indicate that rubratoxin B was both embryoCoxic and teratogenic. It was also dose-dependent. The wide spectrum of gross malformations in the present investigation shows that rubratoxin B has an overall effect on the development of the chick embryos. Like other teratogenic agents this mycotoxin interferes with the early development of the embryonic tissues. Umeda et al. (1970) reported that rubratoxin B increased the mitotic rate of HeLa cells and produced chromosomal damage in postmieotic spermatozoa and described rubratoxin B as a potent mutagen and teratogen. They concluded that the mechanism of rubratoxin B-induced toxicity to the reproductive process was probably electrophilic attack by the lactone moiety to bind to essential mac-

FIG. 2. Seven-day-old embryo showing eye defects, malformations of limbs and neck, cephaly. Embryo was treated with 0.005 mg per egg of rubratoxin on Day 2. x4.

and exen-

204

GILANI,

BANCROFT,

AND REILLY

romolecules irreversibly and inhibit cellular proliferation. In the early stages of heart development, endocardial cushion tissue are rapidly proliferating cellular masses that contribute to the formation of septa and valves (Van Mierop et al., 1962). Administration of rubratoxin B at this stage of cardiac morphogenesis possibly interferes with the growth of cells of endocardial cushion tissue and precipitates their abnormal development. Endocardial cushion defects such as atrial and ventricular defects and malformations of the valves were observed in the present study. The findings in the present study suggest that different doses of rubratoxin B are teratogenic to the overall development of the chick embryos including heart. ACKNOWLEDGMENT This study was supported by The National Foundation-March

of Dimes, White Plains, New York.

REFERENCES Evans, M. A., and Harbison, R. D. (1977). Prenatal toxicity of rubratoxin B and its hydrogenated analog. Toxicol. Appl. Pharmacol. 39,13-22. Hood, R. D., Innes, J. E., and Hayes, A. W. (1973). Effects of rubratoxin B on prenatal development in mice. Bull. Environ. Contam. Toxicol. 10, 200-207. Koshakji, R. P., Wilson, B. J., and Harbison, R. D. (1973). Effect of rubratoxin B on prenatal growth and development in mice. Res. Commun. Chem. Pathol. Pharmacol. 5, 584-592. Sippel, W. L., Bumside, J. E., and Atwood, M. B. (1953). “A Disease of Swine and Cattle Caused by Eating Moldy Corn,” pp. 174-181. Proceedings of the 90th Annual Meeting of the American Veterinary Medical Association. Umeda, M., Saito, A., and Saito, M. (1970). Cytotoxic effects of toxic culture tibrale of Pencillium purpurogenum and its toxic metabohte, rubratoxin B, on HeLa cells. Japan. J. Exp. Med. 40, 490-523. Van Mierop, L. H. S., Alley, R. D., Kausal, H. W., and Stranahan, A. (1962). The anatomy and embryology of endocardial cushion defects. J. Thoruc. Cardiovasc. Surg. 43, 71-83. Wogan, G. N., Edwards, G. S., and Newbern, P. M. (1971). Acute and chronic toxicity of rubratoxin B. Toxicol. Appl. Pharmacol. 19, 712-720.